Oscotec Inc (039200) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.064x

Based on the latest financial reports, Oscotec Inc (039200) has a cash flow conversion efficiency ratio of -0.064x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-7.92 Billion ≈ $-5.37 Million USD) by net assets (₩122.94 Billion ≈ $83.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Oscotec Inc - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Oscotec Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 039200 total liabilities for a breakdown of total debt and financial obligations.

Oscotec Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oscotec Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fujian Nanping Sun Cable Co Ltd SHE:002300	0.077x
Henan Hengxing Science & Technology Co Ltd SHE:002132	0.017x
Ningbo Thermal Power Co Ltd SHG:600982	0.071x
Hyundai Development Co KO:294870	-0.110x
Citic Press Corp SHE:300788	0.020x
Gr. Sarantis S.A. AT:SAR	0.008x
Gracell Biotechnologies Inc. NASDAQ:GRCL	-0.039x
Preformed Line Products Company NASDAQ:PLPC	0.041x

Annual Cash Flow Conversion Efficiency for Oscotec Inc (2011–2024)

The table below shows the annual cash flow conversion efficiency of Oscotec Inc from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Oscotec Inc (039200) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩132.36 Billion ≈ $89.70 Million	₩-26.03 Billion ≈ $-17.64 Million	-0.197x	+15.50%
2023-12-31	₩94.72 Billion ≈ $64.19 Million	₩-22.05 Billion ≈ $-14.94 Million	-0.233x	-7.93%
2022-12-31	₩122.51 Billion ≈ $83.02 Million	₩-26.42 Billion ≈ $-17.91 Million	-0.216x	+29.04%
2021-12-31	₩28.83 Billion ≈ $19.54 Million	₩-8.76 Billion ≈ $-5.94 Million	-0.304x	+9.83%
2020-12-31	₩53.05 Billion ≈ $35.95 Million	₩-17.88 Billion ≈ $-12.12 Million	-0.337x	-63035.38%
2019-12-31	₩51.29 Billion ≈ $34.76 Million	₩27.47 Million ≈ $18.62K	0.001x	+100.49%
2018-12-31	₩46.29 Billion ≈ $31.37 Million	₩-5.08 Billion ≈ $-3.44 Million	-0.110x	+36.83%
2017-12-31	₩21.24 Billion ≈ $14.40 Million	₩-3.69 Billion ≈ $-2.50 Million	-0.174x	+44.31%
2016-12-31	₩26.33 Billion ≈ $17.84 Million	₩-8.21 Billion ≈ $-5.56 Million	-0.312x	-1397.65%
2015-12-31	₩26.92 Billion ≈ $18.24 Million	₩646.84 Million ≈ $438.35K	0.024x	+126.68%
2014-12-31	₩21.78 Billion ≈ $14.76 Million	₩-1.96 Billion ≈ $-1.33 Million	-0.090x	-166.09%
2012-12-31	₩24.47 Billion ≈ $16.58 Million	₩3.34 Billion ≈ $2.26 Million	0.136x	+832.77%
2011-12-31	₩25.73 Billion ≈ $17.43 Million	₩375.90 Million ≈ $254.74K	0.015x	--

About Oscotec Inc

KQ:039200 Korea Pharmaceuticals

Market Cap

$990.30 Million

₩1.46 Trillion KRW

Market Cap Rank

#9160 Global

#261 in Korea

Share Price

₩52000.00

Change (1 day)

-2.80%

52-Week Range

₩25450.00 - ₩62000.00

All Time High

₩66971.21